John Chapman, Pitié-Salpêtrière University Hospital, Paris, France, reviews current understanding of remnant cholesterol as a cardiovascular risk factor, the challenges of isolating remnant particles, and the potential of some remnants as therapeutic targets.
Please login or create a FREE account to view this content
Educational Supporters of the 10th Closed Scientific Expert Meeting of the Editorial Board
Principal supporters:
Guest supporters:
